Drugs / Gelofusin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05874284 | Jun 2023 | decubitus ulcer | Fenerbahce University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06137924 | Dec 2023 → Apr 2024 | — | Universidad Simón Bolívar | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gelofusin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06137924 ↗ |
| Route | Other | “the wound will be washed with gelofusine as prolotherapy” NCT05874284 ↗ |